![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Aberg A, Rydhstroem H, Frid A. Impaired glucose tolerance associated with adverse pregnancy outcome: A population-based study in southern Sweden. American Journal of Obstetrics and Gynecology 2001; 184: 77–83
- Antonetti D A, Barber A J, Khin S, Lieth E, Tarbell J M, Gardner T W. Vascular permeability in experimental diabetes is associated with reduced endothelial occluding content: vascular endothelial growth factor decreased occluding in retinal endothelial cells. Penn State retina research Group. Diabetes 1998; 47: 1953–1959
- Bartha J L, Wood J, Kyle P M, Soothill P W. The effect of metabolic control on fetal nuchal translucency in women with insulin-dependent diabetes: a preliminary study. Ultrasound in Obstetrics and Gynecology 2003; 21: 451–454
- Brausewetter F, Jehle P M, Jung M F, Boehm B O, Brueckel J, Hombach V, , et al. Micro vascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF I) and vascular endothelial growth factor (VEGF). Hormone and Metabolic Research 2001; 33: 713–720
- Fukada Y, Yasumizu T, Takizawa M, Amemiya A, Hoshi K. The prognosis of fetuses with transient nuchal translucency in the first and early second trimester. Acta Obstetricia et Gynecologica Scandinavica 1998; 76: 913–916
- Haak M C, Van Vugt J MG. Pathophysiology of increased nuchal translucency: a review of the literature. Human Reproduction 2003; 9: 175–184
- National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039
- Nicolaides K H, Heath V, Cicero S. Increased fetal nuchal translucency at 11–14 weeks. Prenatal Diagnosis 2002; 22: 308–315
- Plante G E, Chakir M, Ettaouil K, Lehoux S, Sirosis G. Consequences of alteration in capillary permeability. Canadian Journal of Physiology and Pharmacology 1996; 74: 824–833
- Snijder R JM, Noble P, Sebire N, Souka A, Nicolaides K H. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet 1998; 351: 243–346
- Vambergue A, Nuttens M C, Verier-Mine O, Dognin C, Capoen J P, Fontaine P. Is mild gestational hyperglycemia associated with maternal and neonatal complications? The Digest Study. Diabetic Medicine 2000; 17: 203–208